SREBF1 and metabolic dysfunction-associated steatotic liver disease: At the biomolecular level, CA attenuated SREBP1, FAS, acetyl-CoA carboxylase (ACC), and stearoyl-CoA desaturase-1 (SCD1) expression, which are proteins involved in the de novo lipogenesis and generally upregulated in NAFLD.